Tend was founded by Thomas Lendvay, Kathleen Lendvay.

Who are Tend's investors?

Tend's investors include SeaChange, Addition, Good Friends, GV (Google Ventures), JUXTAPOSE VENTURES, Redpoint Ventures, Tiger Global Management, Zigg Capital.

How much funding has Tend raised?

Tend has disclosed $125M raised across 1 of its 3 known rounds.

Where is Tend headquartered?

Tend is headquartered in Seattle, US.

Tend

Seattle, US · 9 known investors

Find your way into Tend

842 people in our graph share verified history with the Tend team — schools, employers, funds. One of them is your warm intro.

Eric Bellunlockedknows Thomas Lendvay · together at C-SATS, Inc. (overlapped)

knows the team · via Seattle Children's

×2knows the team · via CDL-Seattle Computational Health 2021/22

×2knows the team · via Rice University

knows the team · via CVS Pharmacy

×5knows the team · via Emory University School of Medicine

Tend develops therapeutic solutions and diagnostic tools focused on the gut microbiome to treat chronic intestinal and digestive health conditions. The company serves researchers, clinicians, and patients seeking evidence-based alternatives to traditional disease management approaches.

Biotech Healthtech Medical Devices

Founders & leadership

Thomas Lendvay Co-founder & CEOThomas Lendvay is a pediatric urologist and professor at the University of Washington and Seattle Children's Hospital with expertise in surgical technology and medical device design. He co-founded Tend to develop microbiome diagnostics and restoration tools for treating chronic digestive conditions, and also co-founded Singletto, which applies light-activated dye technology to pathogen inactivation.

Kathleen LendvayCo-founder & COO

Investors · 9

SeaChangelisted by SeaChange$250K – $1M

AdditionreportedNew York · $1M – $500M

How we know: funding news · prnewswire.com · Not right? Tell us

Good FriendsreportedSan Francisco · $250K – $1M

How we know: prnewswire.com · Not right? Tell us

GV (Google Ventures)reportedMountain View · $250K – $50M

How we know: funding news · prnewswire.com · Not right? Tell us

JUXTAPOSE VENTURESreportedNew York

How we know: prnewswire.com · Not right? Tell us

Redpoint VenturesreportedWoodside · $100K – $10M

How we know: prnewswire.com · Not right? Tell us

Tiger Global ManagementreportedNew York · $1M – $100M

How we know: prnewswire.com · Not right? Tell us

Zigg CapitalreportedNew York · $4M

How we know: prnewswire.com · Not right? Tell us

Also in the syndicate · 1

Juxtapose

Funding

SEC filings, press & company announcements

$125M disclosed across 1 of 3 rounds · 2019–2021

$125MSeries CApr 2021 · 2 sources
Addition (lead), GV, Juxtapose, Redpoint, Zigg Capital
Source ↗
Undisclosed amountSeries BOct 2020 · 2 sources
GV (lead), Good Friends, Juxtapose, Redpoint, Tiger Global, Zigg Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Tend do?: Tend develops therapeutic solutions and diagnostic tools focused on the gut microbiome to treat chronic intestinal and digestive health conditions. The company serves researchers, clinicians, and patients seeking evidence-based alternatives to traditional disease management approaches.
Who founded Tend?: Tend was founded by Thomas Lendvay, Kathleen Lendvay.
Who are Tend's investors?: Tend's investors include SeaChange, Addition, Good Friends, GV (Google Ventures), JUXTAPOSE VENTURES, Redpoint Ventures, Tiger Global Management, Zigg Capital.
How much funding has Tend raised?: Tend has disclosed $125M raised across 1 of its 3 known rounds.
Where is Tend headquartered?: Tend is headquartered in Seattle, US.